Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma. | Clin Mol Hepatol;26(3): 305-308, 2020 07. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma.

Han, Sojung; Kim, Do Young.

Affiliation

Han S; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Kim DY; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

Clin Mol Hepatol ; 26(3): 305-308, 2020 07.

Article in En | MEDLINE | ID: mdl-32646205

Subject(s)
Key words

Carcinoma, Hepatocellular; Protein kinase inhibitors; Sorafenib

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Limits: Humans Language: En Journal: Clin Mol Hepatol Year: 2020 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Limits: Humans Language: En Journal: Clin Mol Hepatol Year: 2020 Document type: Article Country of publication: